Yuchun Lee - 17 Jan 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
17 Jan 2023
Net transactions value
-$1,065,653
Form type
4
Filing time
19 Jan 2023, 15:07:54 UTC
Previous filing
03 May 2022
Next filing
25 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $288,560 +4,000 +213% $72.14 5,875 17 Jan 2023 Direct
transaction VRTX Common Stock Sale $1,248,120 -4,000 -68% $312.03 1,875 17 Jan 2023 Direct F1, F2, F3
transaction VRTX Common Stock Options Exercise $31,886 +442 +24% $72.14 2,317 18 Jan 2023 Direct
transaction VRTX Common Stock Sale $137,979 -442 -19% $312.17 1,875 18 Jan 2023 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -4,000 -20% $0.000000 16,000 17 Jan 2023 Common Stock 4,000 $72.14 Direct F5
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -442 -2.8% $0.000000 15,558 18 Jan 2023 Common Stock 442 $72.14 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $312.03 (range $312.00 to $312.14).
F4 Open market sales reported on this line occurred at a weighted average price of $312.17 (range $312.00 to $312.53).
F5 Fully vested.